These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26303081)

  • 1. Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease.
    Cathcart P; Lucchesi W; Ottaviani S; De Giorgio A; Krell J; Stebbing J; Castellano L
    Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):529-43. PubMed ID: 26303081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation.
    Ottaviani S; de Giorgio A; Harding V; Stebbing J; Castellano L
    J Mol Endocrinol; 2014 Oct; 53(2):R61-70. PubMed ID: 25062739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNA crosstalk with nuclear receptors in liver disease.
    Wu J; Nagy LE; Liangpunsakul S; Wang L
    Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166083. PubMed ID: 33497819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of RNA metabolism in hormone signaling and breast cancer.
    Wang X; Yang D
    Mol Cell Endocrinol; 2021 Jun; 529():111221. PubMed ID: 33711334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
    Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
    Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of transcription on metabolism in prostate and breast cancers.
    Poulose N; Mills IG; Steele RE
    Endocr Relat Cancer; 2018 Sep; 25(9):R435-R452. PubMed ID: 29760165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis.
    Blundon MA; Dasgupta S
    Endocrinology; 2019 Aug; 160(8):1811-1820. PubMed ID: 31157867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Nuclear Receptors in Prostate Cancer.
    Shiota M; Fujimoto N; Kashiwagi E; Eto M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31212954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.
    Li Z; Yu D; Li H; Lv Y; Li S
    Int J Oncol; 2019 Mar; 54(3):1033-1042. PubMed ID: 30628639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
    Wu C; Luo J
    Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer.
    Leach DA; Powell SM; Bevan CL
    Endocr Relat Cancer; 2016 Nov; 23(11):T85-T108. PubMed ID: 27645052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer.
    Kumar S; Prajapati KS; Singh AK; Kushwaha PP; Shuaib M; Gupta S
    Cancer Lett; 2021 Apr; 504():15-22. PubMed ID: 33556545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA.
    Hayes EL; Lewis-Wambi JS
    Breast Cancer Res; 2015 Mar; 17():40. PubMed ID: 25849966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers.
    Farhan M; Aatif M; Dandawate P; Ahmad A
    Adv Exp Med Biol; 2019; 1152():229-241. PubMed ID: 31456186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
    Niknafs YS; Han S; Ma T; Speers C; Zhang C; Wilder-Romans K; Iyer MK; Pitchiaya S; Malik R; Hosono Y; Prensner JR; Poliakov A; Singhal U; Xiao L; Kregel S; Siebenaler RF; Zhao SG; Uhl M; Gawronski A; Hayes DF; Pierce LJ; Cao X; Collins C; Backofen R; Sahinalp CS; Rae JM; Chinnaiyan AM; Feng FY
    Nat Commun; 2016 Sep; 7():12791. PubMed ID: 27666543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review).
    Cantile M; Cerrone M; Di Bonito M; Moccia P; Tracey M; Ferrara G; Budillon A
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
    Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
    Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
    Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
    Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.
    Alahari SV; Eastlack SC; Alahari SK
    Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.